Mercaptopurin Orion

Mercaptopurine, the active ingredient in Mercaptopurin Orion, is an antimetabolite (purine analog) presented as an oral tablet for oral administration. It is used to treat acute lymphoblastic leukemia, inflammatory bowel disease and to help prevent organ transplant rejection in appropriate patients.

GNH USA supplies Mercaptopurin Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution, ensuring product integrity throughout the supply chain.

Mercaptopurine is employed in several therapeutic areas that involve rapidly proliferating cells or immune modulation.

Acute lymphoblastic leukemia (ALL): contributes to remission by inhibiting DNA synthesis in malignant lymphoblasts. Inflammatory bowel disease (e.g., Crohn’s disease): maintains disease remission by suppressing aberrant immune activity in the gut. Organ transplant rejection prophylaxis: reduces graft rejection risk by dampening T‑cell activation and proliferation. Chronic myeloid leukemia (CML): used as part of combination therapy to control disease progression.

Mercaptopurine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Fatigue - Mild infections - Hair thinning

Serious or Rare Side Effects: - Bone marrow suppression leading to pancytopenia - Severe infections such as sepsis - Hepatotoxicity with elevated liver enzymes - Pancreatitis - Allergic reactions including rash and anaphylaxis - Secondary malignancies (e.g., therapy‑related leukemia)

When using Mercaptopurine, careful monitoring and specific precautions are recommended to minimize risk. - Monitor blood counts: perform regular complete blood count tests to detect myelosuppression early. - Assess liver function: check hepatic enzymes periodically to identify potential hepatotoxicity. - Adjust dose in renal impairment: reduce dosage if renal function is compromised. - Avoid use in known hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original packaging, protect from moisture and light.

Mercaptopurine can interact with several medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Allopurinol: increases mercaptopurine toxicity. - Azathioprine: additive myelosuppression. - TPMT deficiency (genetic): results in severe toxicity.

Moderate Interactions (Monitor Closely): - Methotrexate: may enhance bone marrow suppression. - NSAIDs: can affect renal clearance and increase toxicity.